Cited by

• Stimulating β-cell regeneration by combining a GPR119 agonist with a DPP-IV inhibitor.

  Ansarullah, Lu Y, Holstein M, DeRuyter B, Rabinovitch A, Guo Z. Ansarullah, et al. PLoS One. 2013;8(1):e53345. doi: 10.1371/journal.pone.0053345. Epub 2013 Jan 29. PLoS One. 2013. PMID: 23382843 Free PMC article.
• Combination Therapy Reverses Hyperglycemia in NOD Mice With Established Type 1 Diabetes.

  Xue S, Posgai A, Wasserfall C, Myhr C, Campbell-Thompson M, Mathews CE, Brusko T, Rabinovitch A, Savinov A, Battaglia M, Schatz D, Haller M, Atkinson MA. Xue S, et al. Diabetes. 2015 Nov;64(11):3873-84. doi: 10.2337/db15-0164. Epub 2015 Jul 16. Diabetes. 2015. PMID: 26185279 Free PMC article.
• Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes.

  Haller MJ, Gitelman SE, Gottlieb PA, Michels AW, Perry DJ, Schultz AR, Hulme MA, Shuster JJ, Zou B, Wasserfall CH, Posgai AL, Mathews CE, Brusko TM, Atkinson MA, Schatz DA. Haller MJ, et al. Diabetes. 2016 Dec;65(12):3765-3775. doi: 10.2337/db16-0823. Epub 2016 Sep 26. Diabetes. 2016. PMID: 27669730 Free PMC article. Clinical Trial.
• Regulation of adipocyte differentiation and metabolism by lansoprazole.

  Benchamana A, Mori H, MacDougald OA, Soodvilai S. Benchamana A, et al. Life Sci. 2019 Dec 15;239:116897. doi: 10.1016/j.lfs.2019.116897. Epub 2019 Oct 20. Life Sci. 2019. PMID: 31644894 Free PMC article.
• Dipeptidyl peptidase-4(DPP-4) inhibitors: promising new agents for autoimmune diabetes.

  Wang X, Zheng P, Huang G, Yang L, Zhou Z. Wang X, et al. Clin Exp Med. 2018 Nov;18(4):473-480. doi: 10.1007/s10238-018-0519-0. Epub 2018 Jul 17. Clin Exp Med. 2018. PMID: 30022375 Review.